Drug Index

Oxybate Sodium

Mechanism :

Sodium oxybate is derived from gamma aminobutyric acid (GABA) and acts as an inhibitory chemical transmitter in the brain.

Indication :

  • Narcolepsy: Treatment of cataplexy or excessive daytime sleepiness in patients ≥7 years of age with narcolepsy

Contraindications :

Concomitant use with ethanol or sedative-hypnotic agents; succinic semialdehyde dehydrogenase deficiency.

Dosing :

Use in children ≥7 years orally.
20 to <30 kg: Initial:
Up to 1 g at bedtime, and up to 1 g 2.5 to 4 hours later (up to 2 g per night).
30 to <45 kg: Initial:
Up to 1.5 g at bedtime, and up to 1.5 g 2.5 to 4 hours later (up to 3 g per night).
≥45 kg: Initial:
Up to 2.25 g at bedtime, and up to 2.25 g 2.5 to 4 hours later (up to 4.5 g per night).

Adverse Effect :

Confusion, dizziness, nausea, vomiting, peripheral edema, drowsiness, depression, somnambulism, anxiety, hyperhidrosis, diarrhea, upper abdominal pain, urinary incontinence, tremor, limb pain.

Interaction :

CNS Depressants: Sodium Oxybate may enhance the CNS depressant effect of CNS Depressants.
Selective Serotonin Reuptake Inhibitors: CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors.
Valproate Products: May increase the serum concentration of Sodium Oxybate

Hepatic Dose :

No dosage adjustments are recommended.
03/20/2024 22:26:36 Oxybate Sodium
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0